Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the Exchange Act of 1934, as amended. Confidential Portions are marked: [***]...Plasma Supply Agreement • May 12th, 2015 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 2 to the Plasma Supply Agreement (this “Amendment No. 2”), executed as of March 25, 2015, and deemed to be effective as of February 1, 2015 (“Effective Date”), is by and between Biotest Pharmaceuticals Corporation, a Delaware corporation, having a place of business at 5800 Park of Commerce Boulevard NW, Boca Raton, Florida 33487 (“BPC”) and ADMA Biologics, Inc., a Delaware corporation, having its principal place of business at 465 Route 17 South, Ramsey, New Jersey 07446 (“ADMA”). BPC and ADMA may be referred to collectively herein as the “Parties”, or each as a “Party”.
